Michael Wechsler - National Jewish Health, Denver, CO, USA
Parameswaran Nair - McMaster University and St Joseph's Healthcare, Hamilton, Ontario, Canada
Nader Khalidi - McMaster University
Benjamin Terrier - Hospital Cochin and Université Paris Cité, Paris, France
Bernhard Hellmich - Akademisches Lehrkrankenhaus der Universität Tübingen, Kirchheim unter Teck, Germany
Arnaud Bourdin - Montpellier University Hospitals, Arnaud de Villeneuve Hospital, Montpellier, France
David Jayne - University of Cambridge, Cambridge, UK
David Jackson - Guy's and St Thomas' NHS Trust and King's College London, UK
Florence Roufosse - Université Libre de Bruxelles
Christian Pagnoux - Mount Sinai Hospital and Canadian Vasculitis Research Network (CanVasc), Toronto, ON, Canada
Ulrich Specks - Mayo Clinic
Lena Börjesson Sjö - Late-stage Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
Calvin Ho - Patient Centered Science, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA
Maria Jison - Late-stage Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Christopher McCrae - Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Sofia Necander - Late-stage Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
Eva Rodríguez-Suárez - Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
Anat Shavit - BioPharmaceutials Medical, AstraZeneca, Cambridge, UK
Claire Walton - Late-stage Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
Peter Merkel - University of Pennsylvania